• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Immune reconstitution in recipients of photodepleted HLA-identical sibling donor stem cell transplantations: T cell subset frequencies predict outcome.接受光解离 HLA 相同供体干细胞移植受者的免疫重建:T 细胞亚群频率预测结果。
Biol Blood Marrow Transplant. 2011 Dec;17(12):1846-54. doi: 10.1016/j.bbmt.2011.05.017. Epub 2011 May 30.
2
Selectively T cell-depleted allografts from HLA-matched sibling donors followed by low-dose posttransplantation immunosuppression to improve transplantation outcome in patients with hematologic malignancies.选择性清除 HLA 匹配的同胞供者移植物中的 T 细胞,然后给予低剂量的移植后免疫抑制,以改善血液系统恶性肿瘤患者的移植结果。
Biol Blood Marrow Transplant. 2011 Dec;17(12):1855-61. doi: 10.1016/j.bbmt.2011.05.019. Epub 2011 May 31.
3
Long-term immune reconstitution of naive and memory t cell pools after haploidentical hematopoietic stem cell transplantation.Haploidentical 造血干细胞移植后幼稚和记忆 T 细胞池的长期免疫重建。
Biol Blood Marrow Transplant. 2013 May;19(5):703-12. doi: 10.1016/j.bbmt.2013.01.017. Epub 2013 Feb 8.
4
A clinical-scale selective allodepletion approach for the treatment of HLA-mismatched and matched donor-recipient pairs using expanded T lymphocytes as antigen-presenting cells and a TH9402-based photodepletion technique.一种临床规模的选择性异基因清除方法,用于治疗HLA不匹配和匹配的供体-受体对,该方法使用扩增的T淋巴细胞作为抗原呈递细胞,并采用基于TH9402的光清除技术。
Blood. 2008 Apr 15;111(8):4392-402. doi: 10.1182/blood-2007-08-104471. Epub 2007 Sep 18.
5
Naïve subset develops the most important alloreactive response among human CD4+ T lymphocytes in human leukocyte antigen-identical related setting.在人类白细胞抗原完全相同的相关情况下,幼稚亚群在人类CD4+T淋巴细胞中产生最重要的同种异体反应。
Eur J Haematol. 2014 Jun;92(6):491-6. doi: 10.1111/ejh.12283. Epub 2014 Mar 15.
6
Donor-Recipient Matching for KIR Genotypes Reduces Chronic GVHD and Missing Inhibitory KIR Ligands Protect against Relapse after Myeloablative, HLA Matched Hematopoietic Cell Transplantation.KIR基因型的供受者匹配可减少慢性移植物抗宿主病,且缺乏抑制性KIR配体可预防清髓性、HLA匹配的造血细胞移植后的复发。
PLoS One. 2016 Jun 24;11(6):e0158242. doi: 10.1371/journal.pone.0158242. eCollection 2016.
7
Effect of alemtuzumab-based T-cell depletion on graft compositional change in vitro and immune reconstitution early after allogeneic stem cell transplantation.基于阿仑单抗的 T 细胞耗竭对异基因造血干细胞移植后体外移植物组成变化和早期免疫重建的影响。
Cytotherapy. 2021 Jan;23(1):46-56. doi: 10.1016/j.jcyt.2020.08.003. Epub 2020 Sep 15.
8
[T-cell-depleted HLA non-identical bone marrow transplantation in the child: prevention of graft-versus-host reaction by administration of donor T lymphocytes alloreactive against the recipient].儿童中去除T细胞的HLA不相合骨髓移植:通过给予对受者具有同种异体反应性的供体T淋巴细胞预防移植物抗宿主反应
J Soc Biol. 2001;195(1):65-8.
9
Naive and Stem Cell Memory T Cell Subset Recovery Reveals Opposing Reconstitution Patterns in CD4 and CD8 T Cells in Chronic Graft vs. Host Disease.幼稚和干细胞记忆 T 细胞亚群的恢复揭示了慢性移植物抗宿主病中 CD4 和 CD8 T 细胞重建的相反模式。
Front Immunol. 2019 Mar 6;10:334. doi: 10.3389/fimmu.2019.00334. eCollection 2019.
10
Long-term immune reconstitution and infection burden after mismatched hematopoietic stem cell transplantation.异基因造血干细胞移植后长期免疫重建和感染负担。
Biol Blood Marrow Transplant. 2014 Apr;20(4):507-17. doi: 10.1016/j.bbmt.2014.01.001. Epub 2014 Jan 7.

引用本文的文献

1
Are We Making PROGRESS in Preventing Graft-versus-Host Disease and Improving Clinical Outcomes? Impact of BMT CTN 1301 Study Results on Clinical Practice.我们在预防移植物抗宿主病和改善临床结局方面取得进展了吗?BMT CTN 1301 研究结果对临床实践的影响。
Transplant Cell Ther. 2022 Aug;28(8):419-425. doi: 10.1016/j.jtct.2022.05.002. Epub 2022 May 9.
2
Advances in T Cell Depletion - Where Do We Stand?T细胞清除技术的进展——我们目前的状况如何?
Adv Cell Gene Ther. 2019 Jan;2(1). doi: 10.1002/acg2.29. Epub 2018 Dec 4.
3
Unique features and clinical importance of acute alloreactive immune responses.急性同种反应性免疫应答的独特特征和临床重要性。
JCI Insight. 2018 May 17;3(10). doi: 10.1172/jci.insight.97219.
4
Distinct Biomarker Profiles in Ex Vivo T Cell Depletion Graft Manipulation Strategies: CD34 Selection versus CD3/19 Depletion in Matched Sibling Allogeneic Peripheral Blood Stem Cell Transplantation.在同胞供体外周血造血干细胞移植中,CD34 选择与 CD3/19 耗竭的体外 T 细胞清除移植处理策略的不同生物标志物谱。
Biol Blood Marrow Transplant. 2018 Mar;24(3):460-466. doi: 10.1016/j.bbmt.2017.11.028. Epub 2017 Nov 29.
5
T-Cell Manipulation Strategies to Prevent Graft-Versus-Host Disease in Haploidentical Stem Cell Transplantation.预防单倍体干细胞移植中移植物抗宿主病的T细胞操控策略
Biomedicines. 2017 Jun 21;5(2):33. doi: 10.3390/biomedicines5020033.
6
Targeting T Cell Bioenergetics by Modulating P-Glycoprotein Selectively Depletes Alloreactive T Cells To Prevent Graft-versus-Host Disease.通过调节P-糖蛋白靶向T细胞生物能量学可选择性耗尽同种异体反应性T细胞以预防移植物抗宿主病。
J Immunol. 2016 Sep 1;197(5):1631-41. doi: 10.4049/jimmunol.1402445. Epub 2016 Jul 25.
7
Adenosine Selectively Depletes Alloreactive T Cells to Prevent GVHD While Conserving Immunity to Viruses and Leukemia.腺苷可选择性清除同种异体反应性T细胞以预防移植物抗宿主病,同时保留对病毒和白血病的免疫力。
Mol Ther. 2016 Sep;24(9):1655-64. doi: 10.1038/mt.2016.147. Epub 2016 Jul 6.
8
Selective photodepletion of malignant T cells in extracorporeal photopheresis with selenorhodamine photosensitizers.使用硒罗丹明光敏剂进行体外光化学疗法时对恶性T细胞的选择性光消耗。
Bioorg Med Chem. 2016 Sep 1;24(17):3918-3931. doi: 10.1016/j.bmc.2016.05.071. Epub 2016 Jun 2.
9
Inhibitory effects of merocyanine 540-mediated photodynamic therapy on cellular immune functions: A role in the prophylaxis of graft-versus-host disease?部花青540介导的光动力疗法对细胞免疫功能的抑制作用:在移植物抗宿主病预防中的作用?
J Photochem Photobiol B. 2015 Dec;153:153-63. doi: 10.1016/j.jphotobiol.2015.09.012. Epub 2015 Sep 14.
10
Preventing stem cell transplantation-associated viral infections using T-cell therapy.使用T细胞疗法预防干细胞移植相关病毒感染。
Immunotherapy. 2015;7(7):793-810. doi: 10.2217/imt.15.43. Epub 2015 Aug 7.

本文引用的文献

1
Selectively T cell-depleted allografts from HLA-matched sibling donors followed by low-dose posttransplantation immunosuppression to improve transplantation outcome in patients with hematologic malignancies.选择性清除 HLA 匹配的同胞供者移植物中的 T 细胞,然后给予低剂量的移植后免疫抑制,以改善血液系统恶性肿瘤患者的移植结果。
Biol Blood Marrow Transplant. 2011 Dec;17(12):1855-61. doi: 10.1016/j.bbmt.2011.05.019. Epub 2011 May 31.
2
FOXP3+ regulatory T cells in the human immune system.FOXP3+ 调节性 T 细胞在人类免疫系统中的作用。
Nat Rev Immunol. 2010 Jul;10(7):490-500. doi: 10.1038/nri2785. Epub 2010 Jun 18.
3
Altered regulatory T cell homeostasis in patients with CD4+ lymphopenia following allogeneic hematopoietic stem cell transplantation.异基因造血干细胞移植后 CD4+ 淋巴细胞减少症患者调节性 T 细胞的稳态改变。
J Clin Invest. 2010 May;120(5):1479-93. doi: 10.1172/JCI41072. Epub 2010 Apr 12.
4
The transfer of adaptive immunity to CMV during hematopoietic stem cell transplantation is dependent on the specificity and phenotype of CMV-specific T cells in the donor.造血干细胞移植过程中,对 CMV 的适应性免疫转移取决于供体中 CMV 特异性 T 细胞的特异性和表型。
Blood. 2009 Dec 3;114(24):5071-80. doi: 10.1182/blood-2009-04-214684. Epub 2009 Sep 23.
5
High avidity myeloid leukemia-associated antigen-specific CD8+ T cells preferentially reside in the bone marrow.高亲和力髓系白血病相关抗原特异性CD8 + T细胞优先驻留在骨髓中。
Blood. 2009 Mar 5;113(10):2238-44. doi: 10.1182/blood-2008-04-151969. Epub 2008 Nov 7.
6
Detection of low avidity CD8(+) T cell populations with coreceptor-enhanced peptide-major histocompatibility complex class I tetramers.使用共受体增强的肽-主要组织相容性复合体I类四聚体检测低亲和力CD8(+) T细胞群体。
J Immunol Methods. 2008 Sep 30;338(1-2):31-9. doi: 10.1016/j.jim.2008.07.008. Epub 2008 Jul 31.
7
Adoptive transfer of effector CD8+ T cells derived from central memory cells establishes persistent T cell memory in primates.源自中枢记忆细胞的效应性CD8 + T细胞的过继转移在灵长类动物中建立了持久的T细胞记忆。
J Clin Invest. 2008 Jan;118(1):294-305. doi: 10.1172/JCI32103.
8
A clinical-scale selective allodepletion approach for the treatment of HLA-mismatched and matched donor-recipient pairs using expanded T lymphocytes as antigen-presenting cells and a TH9402-based photodepletion technique.一种临床规模的选择性异基因清除方法,用于治疗HLA不匹配和匹配的供体-受体对,该方法使用扩增的T淋巴细胞作为抗原呈递细胞,并采用基于TH9402的光清除技术。
Blood. 2008 Apr 15;111(8):4392-402. doi: 10.1182/blood-2007-08-104471. Epub 2007 Sep 18.
9
Disease relapse after haematopoietic stem cell transplantation: risk factors and treatment.
Best Pract Res Clin Haematol. 2007 Jun;20(2):311-27. doi: 10.1016/j.beha.2006.10.002.
10
Robust expansion of viral antigen-specific CD4+ and CD8+ T cells for adoptive T cell therapy using gene-modified activated T cells as antigen presenting cells.使用基因修饰的活化T细胞作为抗原呈递细胞,实现用于过继性T细胞疗法的病毒抗原特异性CD4+和CD8+ T细胞的强劲扩增。
J Immunother. 2006 Jul-Aug;29(4):436-43; discussion 365-6. doi: 10.1097/01.cji.0000211302.52503.93.

接受光解离 HLA 相同供体干细胞移植受者的免疫重建:T 细胞亚群频率预测结果。

Immune reconstitution in recipients of photodepleted HLA-identical sibling donor stem cell transplantations: T cell subset frequencies predict outcome.

机构信息

Allotransplantation Section, Hematology Branch, National Heart, Lung and Blood Institute, National Institutes of Health, Bethesda, Maryland 20892, USA.

出版信息

Biol Blood Marrow Transplant. 2011 Dec;17(12):1846-54. doi: 10.1016/j.bbmt.2011.05.017. Epub 2011 May 30.

DOI:10.1016/j.bbmt.2011.05.017
PMID:21684345
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3179560/
Abstract

We evaluated an ex vivo photodepletion (PD) technique to selectively deplete graft-versus-host disease (GVHD) alloreacting T cells given to 24 human leukocyte antigen (HLA)-identical sibling stem cell transplantation (SCT) recipients. Donor lymphocytes were activated by 72-hour exposure to irradiated in vitro expanded recipient T lymphocytes and pulsed with a TH9402 photosensitizer. Alloactivated T cells preferentially retaining the photosensitizer were eliminated by light exposure. The PD product showed an inverted CD4(+)/CD8(+) ratio with greatest depletion occurring in the CD4(+) naive and central memory populations. In contrast, the CD8(+) naive and effector cells were relatively conserved, reflecting the differential extrusion of TH9402 by T cell subsets. Cytomegalovirus reactive T cells were reduced in the PD product and in recipient blood 100 days after SCT when compared with contemporaneous HLA-identical sibling donor T cell-depleted SCT recipients. Although PD SCT recipients experienced similar absolute lymphocyte counts during the first 100 days after SCT, they achieved 100% donor T cell chimerism more rapidly and had higher CD8(+) naive T cell counts early after SCT. SCT recipients of PD products with the lowest CD4 central memory content had the highest risk of developing chronic GVHD (cGVHD) (P = .04) and a poorer survival (P = .03). Although the persistence of CD8(+) naive T cells may have contributed to important antileukemia responses resulting in a relatively low relapse rate, our findings emphasize the role of donor memory T cells and CD4 cells in establishing immune competence post-SCT. Although PD is associated with excellent outcomes in the haploidentical setting, the low frequency of alloactivations in HLA-matched pairs makes the PD approach used by our group for allodepletion in HLA-matched sibling transplantations an inefficient technique.

摘要

我们评估了一种离体光耗竭(PD)技术,用于选择性耗竭异体反应性 T 细胞,该技术用于 24 例人类白细胞抗原(HLA)完全匹配的同胞干细胞移植(SCT)受者。供体淋巴细胞通过 72 小时暴露于辐照的体外扩增的受者 T 淋巴细胞并被 TH9402 光敏剂脉冲激活。优先保留光敏剂的同种激活 T 细胞通过光照消除。PD 产物显示出倒置的 CD4(+)/CD8(+)比值,其中 CD4(+)幼稚和中央记忆群体的耗竭最大。相比之下,CD8(+)幼稚和效应细胞相对保留,这反映了 T 细胞亚群对 TH9402 的不同挤出。与同期 HLA 完全匹配的同胞供体 T 细胞耗竭 SCT 受者相比,SCT 后 100 天 PD 产物和受者血液中的巨细胞病毒反应性 T 细胞减少。尽管 PD SCT 受者在 SCT 后 100 天内经历了类似的绝对淋巴细胞计数,但他们更快地实现了 100%供体 T 细胞嵌合体,并且在 SCT 后早期具有更高的 CD8(+)幼稚 T 细胞计数。PD 产物中 CD4 中央记忆含量最低的 SCT 受者发生慢性移植物抗宿主病(cGVHD)的风险最高(P =.04),生存质量较差(P =.03)。尽管 CD8(+)幼稚 T 细胞的持续存在可能有助于导致相对较低复发率的重要抗白血病反应,但我们的发现强调了供体记忆 T 细胞和 CD4 细胞在 SCT 后建立免疫能力的作用。尽管 PD 在单倍体不相容的情况下与良好的结果相关,但 HLA 匹配对中同种激活的频率较低,使得我们小组在 HLA 匹配的同胞移植中用于同种耗竭的 PD 方法成为一种低效技术。